There is a lot of buzz around Acer Therapeutics (NASDAQ: ACER) resulting in the stock zooming skywards. The sudden interest in the company is based on rumors that the Company is likely to be acquired by Relief Therapeutics (OTCQB: RLFTF), a biopharmaceutical company whose lead...
Kannalife Inc (OTCQB: KLFE), a biopharmaceutical Company developing CBD-based therapeutics for the treatment of neurodegenerative and neuropathic pain disorders, announced the grant of a patent Chinese Patent CN106456573B specific to "Novel Functionalized 1,3-Benzene Diols and their Method of Use for the Treatment of Hepatic Encephalopathy",...
Abeona Therapeutics (NASDAQ: ABEO), a clinical-stage biopharmaceutical Company pioneering cell and gene-based therapies for rare genetic disease, announced positive interim data from two ongoing phase I/II clinical trials evaluating ABO-102 and ABO-101, indicated for the treatment of MPS IIIA and MPS IIIB. The study being...
Cure Pharmaceutical (OTCQB: CURR), a Company leveraging its proprietary drug dosage forms and delivery systems to create innovative therapeutics in collaboration with leading biotech and pharmaceutical companies, announced the signing of an exclusive licensing agreement with ReLeaf Europe, a leading European Medicinal Cannabis Company. ReLeaf...
Canopy Growth (NYSE: CGC), a Canadian cannabis behemoth, announced the launch of a new hemp-derived CBD line for the American market under the brand name “First and Free”, for sale in 31 U.S States where sale of CBD products are legal. This comes on heels...
Sandhoff Disease also referred to as GM2-gangliosidosis Type ll is an autosomal recessive genetic lipid storage disorder that is caused by an abnormal gene for the beta subunit of the hexosaminidase B enzyme. The dysfunction of this gene causes accumulation of lipids called GM2 gangliosides in the...
Mucopolysaccharidosis type III (MPS III), also known as Sanfilippo syndrome, is caused by the mutations in the glucosamine (N-acetyl)-6-sulfatase (GNS), heparan-alpha-glucosaminide N-acetyltransferase (HGSNAT), N-acetyl-alpha-glucosaminidase (NAGLU) and N-sulfoglucosamine sulfohydrolase (SGSH) genes, which are responsible for the synthesis of large sugar molecules called glycosaminoglycans (GAGs). The dysfunction...
Seelos Therapeutics (NASDAQ: SEEL), a clinical-stage biotechnology Company, announced the acceptance of its Investigation New Drug (IND) application for SLS-005 (trehalose) by the FDA. The company is planning to initiate a combined Phase IIb/III, multicenter study to assess the safety, tolerability and efficacy of trehalose...
The shares of Curaleaf (OTCQX: CURLF) surged by almost 15% since the news of its acquisition of Cura Partners, the owner of Select brand, in an all-stock deal valued at C$1.27 billion or US$948.8 million became public. The deal will offer both the companies the ability to diversify and leverage...
The Canadian cannabis behemoth Canopy Growth Inc (NYSE:CGC), a global leader in diversified cannabis and hemp related products, entered into a definitive agreement with Acreage Holdings, Inc (OTCQX: ACRGF) that bestows it with the right to acquire 100 percent of the company’s shares at such time as cannabis production and...
